These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12697940)

  • 1. The medical management of pancreatic cancer: a review.
    McKenna S; Eatock M
    Oncologist; 2003; 8(2):149-60. PubMed ID: 12697940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular targeted therapy for pancreatic adenocarcinoma: A review of completed and ongoing late phase clinical trials.
    Mosquera C; Maglic D; Zervos EE
    Cancer Genet; 2016 Dec; 209(12):567-581. PubMed ID: 27613577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cetuximab: still an option in the treatment of pancreatic cancer?
    Faloppi L; Andrikou K; Cascinu S
    Expert Opin Biol Ther; 2013 May; 13(5):791-801. PubMed ID: 23560505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment options for advanced pancreatic cancer: a review.
    Warsame R; Grothey A
    Expert Rev Anticancer Ther; 2012 Oct; 12(10):1327-36. PubMed ID: 23176620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current perspectives on locally advanced pancreatic cancer.
    Czito BG; Willett CG; Clark JW; Fernandez Del Castillo C
    Oncology (Williston Park); 2000 Nov; 14(11):1535-45; discussion 1546, 1549-52. PubMed ID: 11125940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New therapeutic directions for advanced pancreatic cancer: cell cycle inhibitors, stromal modifiers and conjugated therapies.
    Matera R; Saif MW
    Expert Opin Emerg Drugs; 2017 Sep; 22(3):223-233. PubMed ID: 28783977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Pancreatic Cancer Clinical Trials and Benchmarks for Clinically Meaningful Future Trials: A Systematic Review.
    Rahib L; Fleshman JM; Matrisian LM; Berlin JD
    JAMA Oncol; 2016 Sep; 2(9):1209-16. PubMed ID: 27270617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor receptor-targeted therapy for pancreatic cancer.
    Papageorgio C; Perry MC
    Cancer Invest; 2007 Oct; 25(7):647-57. PubMed ID: 18027154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-angiogenesis therapy in pancreatic carcinoma.
    Saif MW
    JOP; 2006 Mar; 7(2):163-73. PubMed ID: 16525200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Itraconazole therapy in a pancreatic adenocarcinoma patient: A case report.
    Lockhart NR; Waddell JA; Schrock NE
    J Oncol Pharm Pract; 2016 Jun; 22(3):528-32. PubMed ID: 25670260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of chemotherapy in the treatment of advanced gastric and pancreas cancer.
    Kelsen D
    Semin Oncol; 1994 Aug; 21(4 Suppl 7):58-66. PubMed ID: 8091242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status in chemotherapy for advanced pancreatic adenocarcinoma.
    Cao H; LE D; Yang LX
    Anticancer Res; 2013 May; 33(5):1785-91. PubMed ID: 23645722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel agents for the treatment of pancreatic adenocarcinoma: any light at the end of the tunnel? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
    Dimou AT; Syrigos KN; Saif MW
    JOP; 2010 Jul; 11(4):324-7. PubMed ID: 20601803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor receptor-targeted therapy for pancreatic cancer.
    Xiong HQ; Abbruzzese JL
    Semin Oncol; 2002 Oct; 29(5 Suppl 14):31-7. PubMed ID: 12422311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic cancer: a review of emerging therapies.
    Rosenberg L
    Drugs; 2000 May; 59(5):1071-89. PubMed ID: 10852640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consensus report of the international society of gastrointestinal oncology on therapeutic progress in advanced pancreatic cancer.
    Hochster HS; Haller DG; de Gramont A; Berlin JD; Philip PA; Moore MJ; Ajani JA
    Cancer; 2006 Aug; 107(4):676-85. PubMed ID: 16847885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolving concepts regarding the use of radiotherapy in the adjuvant management of periampullary pancreatic adenocarcinoma.
    Abrams RA
    Cancer J; 2012; 18(6):624-32. PubMed ID: 23187851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of systemic therapy in advanced pancreatic carcinoma.
    Lideståhl A; Permert J; Linder S; Bylund H; Edsborg N; Lind P
    Acta Oncol; 2006; 45(2):136-43. PubMed ID: 16546858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brief overview of selected approaches in targeting pancreatic adenocarcinoma.
    Samore WR; Gondi CS
    Expert Opin Investig Drugs; 2014 Jun; 23(6):793-807. PubMed ID: 24673265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes.
    McGuigan A; Kelly P; Turkington RC; Jones C; Coleman HG; McCain RS
    World J Gastroenterol; 2018 Nov; 24(43):4846-4861. PubMed ID: 30487695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.